Daily GLP-1 Injection
A daily injectable GLP-1 receptor agonist that reduces appetite and supports weight loss in adults with obesity. Prescription only, after medical assessment.
Plain English
Patient-Friendly Explanation
Some GLP-1 medications come as a daily injection you give yourself with a small pen. They reduce appetite, slow digestion and help you feel full sooner, supporting steady weight loss over months.
Medical
Clinical Definition
Daily-injected GLP-1 receptor agonists are given once daily by subcutaneous injection, providing continuous receptor activation that reduces appetite, delays gastric emptying and enhances glucose-dependent insulin secretion. Dosing is titrated gradually over weeks to minimise gastrointestinal intolerance such as nausea and vomiting. In weight-management trials, daily GLP-1 receptor agonist therapy produces placebo-subtracted weight loss of roughly 4–6% at about one year, alongside improvements in glycaemic control. Patients are trained in injection technique, site rotation and timing relative to meals; the therapy is an adjunct to lifestyle intervention and is reviewed periodically for ongoing benefit.
Key Insight
Why It Matters
Daily injections sound intimidating, but the pens are designed for easy self-use — most patients master them in one session. Our team teaches the technique, and we pair the medication with a diet plan so reduced hunger translates into real results.
Sources
Reviewed against standard medical references.
Medically reviewed by
Family Physician & Registered Acupuncturist, Accord Medical Clinic. MBBS (NUS), Graduate Diploma in Family Medicine (NUS), Graduate Diploma in Acupuncture (Singapore College of TCM).
Last reviewed: August 2026
This page is general health education, not medical advice. Whether any treatment is appropriate for you is a decision made in consultation after assessment.
